Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Type-2-low severe asthma endotypes for new treatments: the new asthma frontier.

Current opinion in allergy and clinical immunology - 1 Jun 2023

Chung Kian Fan

Abstract excerpt

PURPOSE OF REVIEW: Type-2 (T2)-high asthma represents a well defined group of severe eosinophilic asthma for which there are now effective biologic therapies targetting the interleukins (ILs) 4, 5 and 13, and Immunoglobulin E. T2-low asthma detected in the clinic by a low blood eosinophil count remains ill-defined and is the focus of this review. RECENT FINDINGS: By analysing transcriptomic and proteomic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asthma
Share to Eosinophils
Share to Inflammation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-6

Share to Phenotype

Share to Proteomics

Share to Sputum

Source

Identifiers

PMID: 37185823
DOI: 10.1097/ACI.0000000000000899

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Type-2-low severe asthma endotypes for new treatments: the new asthma frontier.PMID 37185823Read ↗

Asthma Phenotypes and Biomarkers.Semantic proximity Read ↗

Gene signatures in U-BIOPRED severe asthma for molecular phenotyping and precision medicine: time for clinical use.Semantic proximity Read ↗

T2-"Low" Asthma: Overview and Management Strategies.Semantic proximity Read ↗

Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease.Semantic proximity Read ↗

Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.Semantic proximity Read ↗

T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED.Semantic proximity Read ↗

Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes.Semantic proximity Read ↗

Clinical phenotypes of asthma should link up with disease mechanisms.Semantic proximity Read ↗

Precision medicine for the discovery of treatable mechanisms in severe asthmaSemantic proximity Read ↗

The Prevalence of Subtypes of Type 2 Inflammation in an Unselected Population of Patients with Severe Asthma.Semantic proximity Read ↗

Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies.Semantic proximity Read ↗

Phenotypes and Endotypes in Asthma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.